These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 16964426)

  • 1. Comparison of human chorionic gonadotropin +beta and invasive trophoblast antigen disappearance rates in serum after evacuation of molar pregnancy.
    Van Trommel NE; Sweep FC; Ross HA; Massuger LF; Thomas CM
    Int J Mol Med; 2006 Oct; 18(4):705-11. PubMed ID: 16964426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical utility of hyperglycosylated hCG in serum taken before hydatidiform mole evacuation to predict persistent trophoblastic disease.
    Duc HN; van Trommel NE; Sweep FC; Massuger LF; Thomas CM
    Int J Biol Markers; 2006; 21(1):45-9. PubMed ID: 16711513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of hydatidiform mole and persistent trophoblastic disease: diagnostic accuracy of total human chorionic gonadotropin (hCG), free hCG {alpha}- and {beta}-subunits, and their ratios.
    van Trommel NE; Sweep FC; Schijf CP; Massuger LF; Thomas CM
    Eur J Endocrinol; 2005 Oct; 153(4):565-75. PubMed ID: 16189178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-evacuation hCG glycoforms in uneventful complete hydatidiform mole and persistent trophoblastic disease.
    Thomas CM; Kerkmeijer LG; Ariaens HJ; van der Steen RC; Massuger LF; Sweep FC
    Gynecol Oncol; 2010 Apr; 117(1):47-52. PubMed ID: 20116088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent trophoblast disease following partial molar pregnancy.
    Wielsma S; Kerkmeijer L; Bekkers R; Pyman J; Tan J; Quinn M
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of persistent trophoblastic diseases based on a human chorionic gonadotropin regression curve by means of a stepwise piecewise linear regression analysis after the evacuation of uneventful moles.
    Shigematsu T; Kamura T; Saito T; Kaku T; Nakano H; Kinugawa N
    Gynecol Oncol; 1998 Dec; 71(3):376-80. PubMed ID: 9887234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
    Kerkmeijer LG; Wielsma S; Massuger LF; Sweep FC; Thomas CM
    Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early identification of resistance to first-line single-agent methotrexate in patients with persistent trophoblastic disease.
    van Trommel NE; Massuger LF; Schijf CP; ten Kate-Booij MJ; Sweep FC; Thomas CM
    J Clin Oncol; 2006 Jan; 24(1):52-8. PubMed ID: 16382113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma human chorionic gonadotropin disappearance in hydatidiform mole: a central registry report from the Netherlands.
    Franke HR; Risse EK; Kenemans P; Houx PC; Stolk JG; Vooijs GP
    Obstet Gynecol; 1983 Oct; 62(4):467-73. PubMed ID: 6888825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of prophylactic chemotherapy outcome and clinical characteristics in patients of high-risk hydatidiform mole].
    Geng S; Feng FZ; Xiang Y; Wan XR; Zhou Y
    Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):24-7. PubMed ID: 21429430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydatidiform mole and post-evacuation regression patterns of serum beta human chorionic gonadotrophin.
    Kamariah K; Satgunasingam N; Nasri NM; Ng KY
    Med J Malaysia; 1993 Mar; 48(1):40-5. PubMed ID: 7688063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating methotrexate treatment in patients with low-risk postmolar gestational trophoblastic neoplasia.
    Growdon WB; Wolfberg AJ; Goldstein DP; Feltmate CM; Chinchilla ME; Lieberman ES; Berkowitz RS
    Gynecol Oncol; 2009 Feb; 112(2):353-7. PubMed ID: 19059633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum human chorionic gonadotropin regression pattern in persistent trophoblastic disease during chemotherapy.
    Lertkhachonsuk R; Limpongsanurak S
    J Med Assoc Thai; 2001 Jun; 84 Suppl 1():S352-9. PubMed ID: 11529357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence of gestational trophoblastic disease for longer than 1 year following evacuation of hydatidiform mole.
    Elmer DB; Granai CO; Ball HG; Curry SL
    Obstet Gynecol; 1993 May; 81(5 ( Pt 2)):888-90. PubMed ID: 7682320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rapid solid-phase radioimmunoassay specific for human chorionic gonadotropin in gestational trophoblastic disease.
    Goldstein DP; Pastorfide GB; Osathanondh R; Kosasa TS
    Obstet Gynecol; 1975 May; 45(5):527-30. PubMed ID: 164644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gestational trophoblastic diseases - clinical guidelines for diagnosis, treatment, follow-up, and counselling.
    Niemann I; Vejerslev LO; Frøding L; Blaakær J; Maroun LL; Hansen ES; Grove A; Lund H; Havsteen H; Sunde L
    Dan Med J; 2015 Nov; 62(11):A5082. PubMed ID: 26522484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal human chorionic gonadotropin regression curves in uneventful postmolar patients.
    Kizaki S; Matsui H; Usui H; Shozu M; Hanawa S; Yamamoto E; Kikkawa F
    J Reprod Med; 2012; 57(5-6):243-8. PubMed ID: 22696820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Trophoblastic diseases].
    ten Kate-Booij MJ; Lok CA; Verheijen RH; Massuger LF; van Trommel NE
    Ned Tijdschr Geneeskd; 2008 Oct; 152(41):2219-24. PubMed ID: 19009808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human chorionic gonadotrophin regression rate as a predictive factor of postmolar gestational trophoblastic neoplasm in high-risk hydatidiform mole: a case-control study.
    Kim BW; Cho H; Kim H; Nam EJ; Kim SW; Kim S; Kim YT; Kim JH
    Eur J Obstet Gynecol Reprod Biol; 2012 Jan; 160(1):100-5. PubMed ID: 22055909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum progesterone monitoring in post-molar surveillance.
    Vasilev SA; Schlaerth JB; Ahn C; Sauer MV
    Gynecol Oncol; 1994 Sep; 54(3):288-91. PubMed ID: 7522199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.